Recommendations for the management of pericardial diseases
DOI:
https://doi.org/10.6016/ZdravVestn.3027Keywords:
acute pericarditis, constrictive pericarditis, pericardial effusion, tamponadeAbstract
The pericardium may be affected as an isolated process or as part of a systemic disease. In developed countries (with a low prevalence of tuberculosis), the most common aetiologies are presumed to be viral, immune-mediated forms (systemic inflammatory diseases, post-cardiac injury syndromes) and cancer. In clinical practice, there are few general presentations with distinctive signs and symptoms that are referred to as pericardial syndromes: pericarditis, isolated pericardial effusion, cardiac tamponade, constrictive pericarditis and pericardial masses and cysts. In the latest European Society of Cardiology guidelines for pericardial disease new diagnostic strategies have been proposed for the triage of patients with pericarditis and pericardial effusion, and specific diagnostic criteria have been established for acute and recurrent pericarditis. Moreover, new therapeutic strategies have emerged. The article covers a translation of ESC Guidelines on the Diagnosis and Management of Pericardial Diseases adapted to our situation.
Downloads
References
1. Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed By: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921-64.
DOI: 10.1093/eurheartj/ehv318
PMID: 26320112
2. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y, et al.; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004;25(7):587-610.
DOI: 10.1016/j.ehj.2004.02.002
PMID: 15120056
3. Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739-44.
DOI: 10.1161/CIRCULATIONAHA.106.662114
PMID: 17502574
4. Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042-6.
DOI: 10.1016/j.jacc.2003.09.055
PMID: 15028364
5. Černe A, Poglajen G, Lejko Zupanc T, Berden P, Koželj M. Predlog obravnave bonika s sumom na miokarditis. Slov Kardiol. 2014;11(1):52-61.
6. Imazio M, Brucato A, Derosa FG, Lestuzzi C, Bombana E, Scipione F, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown). 2009;10(3):217-30.
DOI: 10.2459/JCM.0b013e328322f9b1
PMID: 19262208
7. Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, et al.; European Association of Cardiovascular Imaging (EACVI); European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging. 2015;16(1):12-31.
DOI: 10.1093/ehjci/jeu128
PMID: 25248336
8. Imazio M, Adler Y. Pharmacological therapy of pericardial diseases. Curr Pharm Des. 2015;21(4):525-30.
DOI: 10.2174/138161282104141204144622
PMID: 25483954
9. Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al.; ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522-8.
DOI: 10.1056/NEJMoa1208536
PMID: 23992557
10. Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667-71.
DOI: 10.1161/CIRCULATIONAHA.107.761064
PMID: 18645054
11. Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383(9936):2232-7.
DOI: 10.1016/S0140-6736(13)62709-9
PMID: 24694983
12. Imazio M, Adler Y, Charron P. Recurrent Pericarditis: modern Approach in 2016. Curr Cardiol Rep. 2016;18(6):50.
DOI: 10.1007/s11886-016-0727-8
PMID: 27108360
13. Moretti M, Buiatti A, Merlo M, Massa L, Fabris E, Pinamonti B, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol. 2013;112(9):1493-8.
DOI: 10.1016/j.amjcard.2013.06.036
PMID: 23972350
14. Imazio M, Andreis A, De Ferrari GM, et al. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP study. Eur J Prev Cardiol. 2019;27(9):1-9.
DOI: 10.1177/2047487319879534
PMID: 31610707
15. Vianello F, Cinetto F, Cavraro M, Battisti A, Castelli M, Imbergamo S, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011;147(3):477-8.
DOI: 10.1016/j.ijcard.2011.01.027
PMID: 21296434
16. Khandaker MH, Schaff HV, Greason KL, Anavekar NS, Espinosa RE, Hayes SN, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012;87(11):1062-70.
DOI: 10.1016/j.mayocp.2012.05.024
PMID: 23127733
17. Imazio M, Brucato A, Barbieri A, Ferroni F, Maestroni S, Ligabue G, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013;128(1):42-9.
DOI: 10.1161/CIRCULATIONAHA.113.001531
PMID: 23709669
18. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48.
DOI: 10.1093/eurheartj/eht210
PMID: 23824828
19. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al.; Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-79.
DOI: 10.1016/S0140-6736(13)60900-9
PMID: 23726390
20. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186-97.
DOI: 10.1093/eurheartj/ehs372
PMID: 23125278
21. Sagristà-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999;341(27):2054-9.
DOI: 10.1056/NEJM199912303412704
PMID: 10615077
22. Ristić AD, Imazio M, Adler Y, Anastasakis A, Badano LP, Brucato A, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35(34):2279-84.
DOI: 10.1093/eurheartj/ehu217
PMID: 25002749
23. Imazio M, Brucato A, Adler Y, Brambilla G, Artom G, Cecchi E, et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am J Cardiol. 2007;100(6):1026-8.
DOI: 10.1016/j.amjcard.2007.04.047
PMID: 17826391
24. Syed FF, Schaff HV, Oh JK. Constrictive pericarditis—a curable diastolic heart failure. Nat Rev Cardiol. 2014;11(9):530-44.
DOI: 10.1038/nrcardio.2014.100
PMID: 25072910
25. Mahfoud F, Gärtner B, Kindermann M, Ukena C, Gadomski K, Klingel K, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 2011;32(7):897-903.
DOI: 10.1093/eurheartj/ehq493
PMID: 21217143
26. Reuter H, Burgess LJ, Louw VJ, Doubell AF. The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr. 2007;18(1):20-5.
PMID: 17392991
27. Augustin P, Desmard M, Mordant P, Lasocki S, Maury JM, Heming N, et al. Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis. Crit Care. 2011;15(2):220.
DOI: 10.1186/cc10022
PMID: 21575282
28. Alpert MA, Ravenscraft MD. Pericardial involvement in end-stage renal disease. Am J Med Sci. 2003;325(4):228-36.
DOI: 10.1097/00000441-200304000-00009
PMID: 12695728
29. Imazio M. Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options. Expert Rev Clin Immunol. 2014;10(11):1487-92.
DOI: 10.1586/1744666X.2014.965150
PMID: 25307995
30. Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, et al.; COPPS-2 Investigators. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016-23.
DOI: 10.1001/jama.2014.11026
PMID: 25172965
31. Imazio M, Brucato A, Markel G, Cemin R, Trinchero R, Spodick DH, et al. Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome. Am J Cardiol. 2011;108(4):575-9.
DOI: 10.1016/j.amjcard.2011.03.087
PMID: 21624554
32. Holmes DR, Nishimura R, Fountain R, Turi ZG. Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv. 2009;2(8):705-17.
DOI: 10.1016/j.jcin.2009.04.019
PMID: 19695538
33. Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al.; American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26(9):1013-32.
DOI: 10.1016/j.echo.2013.07.005
PMID: 23998694
34. Maisch B, Ristic A, Pankuweit S. Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53(2):157-63.
DOI: 10.1016/j.pcad.2010.06.003
PMID: 20728703
35. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-9.
DOI: 10.1056/NEJM200102153440707
PMID: 11172193
36. Fenstad ER, Le RJ, Sinak LJ, Maradit-Kremers H, Ammash NM, Ayalew AM, et al. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. Chest. 2013;144(5):1530-8.
DOI: 10.1378/chest.12-3033
PMID: 23949692
37. Imazio M, Brucato A, Rampello S, Armellino F, Trinchero R, Spodick DH, et al. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11(8):557-62.
DOI: 10.2459/JCM.0b013e3283352356
PMID: 20389257
38. Maisch B, Ristic AD, Seferovic M, Tsang SM. Interventional pericardiology: peri- cardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy, and intrapericardial therapy. Heidelberg: Springer; 2011.
DOI: 10.1007/978-3-642-11335-2
Downloads
Published
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
